{
    "SPADE_UN_28654": {
        "Sequence Information": {
            "Peptide Name": "Protaetiamycine 9Pbw3",
            "Sequence": "RLWLAIWRR",
            "Sequence Length": 9,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action.",
                    "Pubmed ID": "19598182",
                    "Reference": "J Pept Sci. 2009;15:559-568",
                    "Author": "Shin S, Kim JK, Lee JY, Jung KW, Hwang JS, Lee J, Lee DG, Kim I, Shin SY, Kim Y",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19598182"
                },
                {
                    "Title": "Enantiomeric 9-mer Peptide Analogs of Protaetiamycine With Bacterial Cell Selectivities and Anti-Inflammatory Activities",
                    "Pubmed ID": "21766387",
                    "Reference": "J Pept Sci. 2011;17:675-682",
                    "Author": "Lee E, Kim JK, Shin S, Jeong KW, Lee J, Lee DG, Hwang JS, Kim Y",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21766387"
                }
            ],
            "Mass": 1269.54,
            "PI": 12.0,
            "Net Charge": 3,
            "Hydrophobicity": -0.16,
            "Frequent Amino Acids": "RLW",
            "Absent Amino Acids": "CDEFGHKMNOPQSTUVY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 4,
            "Polar Residues": 5,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_28654",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_01102",
                    "Similarity": 1.0,
                    "Sequence": "WVRLWWRRVW"
                },
                {
                    "SPADE_ID": "SPADE_UN_02882",
                    "Similarity": 1.0,
                    "Sequence": "VVALQRRLW"
                },
                {
                    "SPADE_ID": "SPADE_UN_05235",
                    "Similarity": 1.0,
                    "Sequence": "WRLRRFRLW"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:100% Hemolysis=25 µM,Human erythrocytes:10% Hemolysis=50 µM,Human erythrocytes:30% Hemolysis=100 µM",
            "Target Organism": "Escherichia coli KCTC 1682(MIC=2µM),Pseudomonas aeruginosa KCTC 1637(MIC=8-16µM),Salmonella typhimurium KCTC 1926(MIC=8µM),Bacillus subtilis KCTC 3068(MIC=2µM),Staphylococcus epidermidis KCTC 1917(MIC=1µM),Staphylococcus aureus KCTC 1621(MIC=2µM),Staphylococcus aureus CCARM 3089(MIC=2µM),Staphylococcus aureus CCARM 3114(MIC=4µM),Salmonella typhimurium CCARM 8003(MIC=16µM),Salmonella typhimurium CCARM 8009(MIC=8µM),Escherichia coli CCARM 1229(MIC=8µM),Escherichia coli CCARM 1238(MIC=4µM),Murine macrophage cells RAW 264.7(50% Cell death=25µM)"
        }
    }
}